Samlyn Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Samlyn Capital’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-687,862	Closed	-$30M	–	162
2017 Q4	$30M	Sell	687,862 -23,555	-3%	-$1.1M	0.69%	58
2017 Q3	$37.2M	Sell	711,417 -309,989	-30%	-$17.3M	0.94%	35
2017 Q2	$59.8M	Buy	1,021,406 +244,457	+31%	+$12.7M	1.46%	22
2017 Q1	$35.6M	Buy	776,949 +254,094	+49%	+$12.6M	0.83%	54
2016 Q4	$27.5M	Buy	522,855 +57,185	+12%	+$2.77M	0.62%	62
2016 Q3	$20.8M	Buy	+465,670	New	+$20.2M	0.49%	75

Other funds holding SYNH

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Samlyn Capital's SYNH Position: Q1 2018 in Review

Samlyn Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2018, closing a stake of 687,862 shares — an estimated $30M sold.

Samlyn Capital first reported a position in SYNH in Q3 2016 and held it in 6 quarters. The position peaked at $59.8M in Q2 2017. 218 funds tracked by Wall St. Rank hold SYNH as of Q1 2018.

Samlyn Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2018 after selling out during the quarter.
Samlyn Capital sold 687,862 Syneos Health, Inc. Class A Common Stock shares in Q1 2018, an estimated $30M.
Samlyn Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2016 and held it in 6 quarters.
Samlyn Capital's Syneos Health, Inc. Class A Common Stock position peaked at $59.8M in Q2 2017.
218 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2018.

Based on Samlyn Capital's 13F filing for Q1 2018, filed 15 May 2018.